Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 0 | $0 |
Sells | 322 | $203,380,051 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
18 May 2022 16:21 | VRTX | VERTEX PHARMACEUTICALS INC | ARBUCKLE STUART A | EVP, COO | 16 May 2022 | Sale | 40 | 254.19 | 10,168 | D |
18 May 2022 16:21 | VRTX | VERTEX PHARMACEUTICALS INC | ARBUCKLE STUART A | EVP, COO | 16 May 2022 | Sale | 10 | 252.66 | 2,527 | D |
18 May 2022 16:21 | VRTX | VERTEX PHARMACEUTICALS INC | ARBUCKLE STUART A | EVP, COO | 16 May 2022 | Sale | 10 | 251.43 | 2,514 | D |
18 May 2022 16:21 | VRTX | VERTEX PHARMACEUTICALS INC | ARBUCKLE STUART A | EVP, COO | 16 May 2022 | Sale | 32 | 250.78 | 8,025 | D |
18 May 2022 16:21 | VRTX | VERTEX PHARMACEUTICALS INC | ARBUCKLE STUART A | EVP, COO | 16 May 2022 | Sale | 20 | 249.35 | 4,987 | D |
18 May 2022 16:21 | VRTX | VERTEX PHARMACEUTICALS INC | ARBUCKLE STUART A | EVP, COO | 16 May 2022 | Sale | 10 | 247.95 | 2,480 | D |
18 May 2022 16:21 | VRTX | VERTEX PHARMACEUTICALS INC | ARBUCKLE STUART A | EVP, COO | 16 May 2022 | Sale | 11 | 246.21 | 2,708 | D |
18 May 2022 16:22 | VRTX | VERTEX PHARMACEUTICALS INC | SANNA BASTIANO | EVP, Cell & Genetic Therapies | 16 May 2022 | Sale | 8 | 254.44 | 2,036 | D |
18 May 2022 16:22 | VRTX | VERTEX PHARMACEUTICALS INC | SANNA BASTIANO | EVP, Cell & Genetic Therapies | 16 May 2022 | Sale | 15 | 253.99 | 3,810 | D |
18 May 2022 16:22 | VRTX | VERTEX PHARMACEUTICALS INC | SANNA BASTIANO | EVP, Cell & Genetic Therapies | 16 May 2022 | Sale | 7 | 252.43 | 1,767 | D |
18 May 2022 16:22 | VRTX | VERTEX PHARMACEUTICALS INC | SANNA BASTIANO | EVP, Cell & Genetic Therapies | 16 May 2022 | Sale | 8 | 251.37 | 2,011 | D |
18 May 2022 16:22 | VRTX | VERTEX PHARMACEUTICALS INC | SANNA BASTIANO | EVP, Cell & Genetic Therapies | 16 May 2022 | Sale | 7 | 250.56 | 1,754 | D |
18 May 2022 16:18 | VRTX | VERTEX PHARMACEUTICALS INC | LIU JOY | SVP, General Counsel | 16 May 2022 | Sale | 35 | 254.36 | 8,903 | D |
18 May 2022 16:18 | VRTX | VERTEX PHARMACEUTICALS INC | LIU JOY | SVP, General Counsel | 16 May 2022 | Sale | 34 | 253.87 | 8,632 | D |
18 May 2022 16:18 | VRTX | VERTEX PHARMACEUTICALS INC | LIU JOY | SVP, General Counsel | 16 May 2022 | Sale | 20 | 252.49 | 5,050 | D |
18 May 2022 16:18 | VRTX | VERTEX PHARMACEUTICALS INC | LIU JOY | SVP, General Counsel | 16 May 2022 | Sale | 19 | 251.57 | 4,780 | D |
18 May 2022 16:18 | VRTX | VERTEX PHARMACEUTICALS INC | LIU JOY | SVP, General Counsel | 16 May 2022 | Sale | 25 | 250.77 | 6,269 | D |
06 May 2022 16:05 | VRTX | VERTEX PHARMACEUTICALS INC | SANNA BASTIANO | EVP, Cell & Genetic Therapies | 04 May 2022 | Sale | 36 | 275.09 | 9,903 | D |
04 May 2022 17:21 | VRTX | VERTEX PHARMACEUTICALS INC | ARBUCKLE STUART A | EVP, COO | 02 May 2022 | Sale | 306 | 263.98 | 80,778 | D |
04 May 2022 17:09 | VRTX | VERTEX PHARMACEUTICALS INC | BHATIA SANGEETA N. | Director | 02 May 2022 | Sale | 6 | 264.37 | 1,586 | D |
04 May 2022 17:09 | VRTX | VERTEX PHARMACEUTICALS INC | BHATIA SANGEETA N. | Director | 02 May 2022 | Sale | 91 | 261.91 | 23,834 | D |
04 May 2022 17:09 | VRTX | VERTEX PHARMACEUTICALS INC | BHATIA SANGEETA N. | Director | 02 May 2022 | Sale | 80 | 260.82 | 20,866 | D |
04 May 2022 17:09 | VRTX | VERTEX PHARMACEUTICALS INC | BHATIA SANGEETA N. | Director | 02 May 2022 | Sale | 120 | 259.75 | 31,170 | D |
04 May 2022 17:09 | VRTX | VERTEX PHARMACEUTICALS INC | BHATIA SANGEETA N. | Director | 02 May 2022 | Sale | 120 | 258.9 | 31,068 | D |
04 May 2022 17:09 | VRTX | VERTEX PHARMACEUTICALS INC | BHATIA SANGEETA N. | Director | 02 May 2022 | Sale | 280 | 257.51 | 72,103 | D |
04 May 2022 17:09 | VRTX | VERTEX PHARMACEUTICALS INC | BHATIA SANGEETA N. | Director | 02 May 2022 | Sale | 40 | 255.4 | 10,216 | D |
04 May 2022 17:10 | VRTX | VERTEX PHARMACEUTICALS INC | SANNA BASTIANO | EVP, Cell & Genetic Therapies | 02 May 2022 | Sale | 4 | 264.37 | 1,057 | D |
04 May 2022 17:10 | VRTX | VERTEX PHARMACEUTICALS INC | SANNA BASTIANO | EVP, Cell & Genetic Therapies | 02 May 2022 | Sale | 65 | 261.79 | 17,016 | D |
04 May 2022 17:10 | VRTX | VERTEX PHARMACEUTICALS INC | SANNA BASTIANO | EVP, Cell & Genetic Therapies | 02 May 2022 | Sale | 23 | 260.44 | 5,990 | D |
04 May 2022 17:10 | VRTX | VERTEX PHARMACEUTICALS INC | SANNA BASTIANO | EVP, Cell & Genetic Therapies | 02 May 2022 | Sale | 75 | 259.58 | 19,468 | D |
04 May 2022 17:10 | VRTX | VERTEX PHARMACEUTICALS INC | SANNA BASTIANO | EVP, Cell & Genetic Therapies | 02 May 2022 | Sale | 43 | 258.46 | 11,114 | D |
04 May 2022 17:10 | VRTX | VERTEX PHARMACEUTICALS INC | SANNA BASTIANO | EVP, Cell & Genetic Therapies | 02 May 2022 | Sale | 90 | 257.49 | 23,174 | D |
04 May 2022 17:10 | VRTX | VERTEX PHARMACEUTICALS INC | SANNA BASTIANO | EVP, Cell & Genetic Therapies | 02 May 2022 | Sale | 20 | 255.47 | 5,109 | D |
04 May 2022 17:07 | VRTX | VERTEX PHARMACEUTICALS INC | WAGNER CHARLES F JR | EVP & Chief Financial Officer | 02 May 2022 | Sale | 3 | 264.37 | 793 | D |
04 May 2022 17:07 | VRTX | VERTEX PHARMACEUTICALS INC | WAGNER CHARLES F JR | EVP & Chief Financial Officer | 02 May 2022 | Sale | 32 | 262.06 | 8,386 | D |
04 May 2022 17:07 | VRTX | VERTEX PHARMACEUTICALS INC | WAGNER CHARLES F JR | EVP & Chief Financial Officer | 02 May 2022 | Sale | 48 | 261.15 | 12,535 | D |
04 May 2022 17:07 | VRTX | VERTEX PHARMACEUTICALS INC | WAGNER CHARLES F JR | EVP & Chief Financial Officer | 02 May 2022 | Sale | 80 | 259.45 | 20,756 | D |
04 May 2022 17:07 | VRTX | VERTEX PHARMACEUTICALS INC | WAGNER CHARLES F JR | EVP & Chief Financial Officer | 02 May 2022 | Sale | 60 | 258.21 | 15,493 | D |
04 May 2022 17:07 | VRTX | VERTEX PHARMACEUTICALS INC | WAGNER CHARLES F JR | EVP & Chief Financial Officer | 02 May 2022 | Sale | 100 | 257.18 | 25,718 | D |
04 May 2022 17:07 | VRTX | VERTEX PHARMACEUTICALS INC | WAGNER CHARLES F JR | EVP & Chief Financial Officer | 02 May 2022 | Sale | 20 | 254.87 | 5,097 | D |
27 Feb 2024 16:59 | VRTX | VERTEX PHARMACEUTICALS INC | SACHDEV AMIT | EVP Chief Patient & Ext Af Off | 26 Feb 2024 | Sale | 3,004 | 425.7 | 1,278,803 | D |
27 Feb 2024 17:02 | VRTX | VERTEX PHARMACEUTICALS INC | TATSIS OURANIA | EVP, Chief Reg. & Quality Off. | 26 Feb 2024 | Sale | 354 | 425.7 | 150,698 | D |
27 Feb 2024 16:44 | VRTX | VERTEX PHARMACEUTICALS INC | ATKINSON EDWARD MORROW III | EVP, Chief Technical Ops. Off. | 26 Feb 2024 | Sale | 883 | 425.7 | 375,893 | D |
27 Feb 2024 16:37 | VRTX | VERTEX PHARMACEUTICALS INC | ARBUCKLE STUART A | EVP, COO | 26 Feb 2024 | Sale | 5,034 | 425.7 | 2,142,974 | D |
27 Feb 2024 16:29 | VRTX | VERTEX PHARMACEUTICALS INC | AMBROSE KRISTEN | SVP & Chief Accounting Officer | 26 Feb 2024 | Sale | 883 | 425.7 | 375,893 | D |
27 Feb 2024 16:24 | VRTX | VERTEX PHARMACEUTICALS INC | ALTSHULER DAVID | EVP, Global Research and CSO | 26 Feb 2024 | Sale | 4,239 | 425.7 | 1,804,542 | D |
23 Feb 2024 16:20 | VRTX | VERTEX PHARMACEUTICALS INC | SACHDEV AMIT | EVP Chief Patient & Ext Af Off | 21 Feb 2024 | Sale | 3,191 | 421.77 | 1,345,868 | D |
23 Feb 2024 16:28 | VRTX | VERTEX PHARMACEUTICALS INC | TATSIS OURANIA | EVP, Chief Reg. & Quality Off. | 21 Feb 2024 | Sale | 360 | 421.77 | 151,837 | D |
23 Feb 2024 16:16 | VRTX | VERTEX PHARMACEUTICALS INC | ATKINSON EDWARD MORROW III | EVP, Chief Technical Ops. Off. | 21 Feb 2024 | Sale | 1,201 | 421.77 | 506,546 | D |
23 Feb 2024 16:10 | VRTX | VERTEX PHARMACEUTICALS INC | ALTSHULER DAVID | EVP, Global Research and CSO | 21 Feb 2024 | Sale | 3,002 | 421.77 | 1,266,154 | D |
23 Feb 2024 16:12 | VRTX | VERTEX PHARMACEUTICALS INC | ARBUCKLE STUART A | EVP, COO | 21 Feb 2024 | Sale | 3,603 | 421.77 | 1,519,637 | D |
21 Feb 2024 16:43 | VRTX | VERTEX PHARMACEUTICALS INC | TATSIS OURANIA | EVP, Chief Reg. & Quality Off. | 20 Feb 2024 | Sale | 480 | 420.79 | 201,979 | D |
21 Feb 2024 16:38 | VRTX | VERTEX PHARMACEUTICALS INC | SACHDEV AMIT | EVP Chief Patient & Ext Af Off | 20 Feb 2024 | Sale | 4,254 | 420.79 | 1,790,041 | D |
21 Feb 2024 16:23 | VRTX | VERTEX PHARMACEUTICALS INC | ATKINSON EDWARD MORROW III | EVP, Chief Technical Ops. Off. | 20 Feb 2024 | Sale | 801 | 420.79 | 337,053 | D |
21 Feb 2024 16:19 | VRTX | VERTEX PHARMACEUTICALS INC | ARBUCKLE STUART A | EVP, COO | 20 Feb 2024 | Sale | 4,804 | 420.79 | 2,021,475 | D |
21 Feb 2024 16:13 | VRTX | VERTEX PHARMACEUTICALS INC | ALTSHULER DAVID | EVP, Global Research and CSO | 20 Feb 2024 | Sale | 4,002 | 420.79 | 1,684,002 | D |
16 Feb 2024 16:07 | VRTX | VERTEX PHARMACEUTICALS INC | LEIDEN JEFFREY M | Executive Chairman | 15 Feb 2024 | Sale | 4,655 | 419.16 | 1,951,190 | D |
16 Feb 2024 16:07 | VRTX | VERTEX PHARMACEUTICALS INC | LEIDEN JEFFREY M | Executive Chairman | 14 Feb 2024 | Sale | 4,356 | 419.04 | 1,825,338 | D |
14 Feb 2024 16:04 | VRTX | VERTEX PHARMACEUTICALS INC | LEIDEN JEFFREY M | Executive Chairman | 13 Feb 2024 | Sale | 737 | 419.13 | 308,899 | D |
14 Feb 2024 16:04 | VRTX | VERTEX PHARMACEUTICALS INC | LEIDEN JEFFREY M | Executive Chairman | 12 Feb 2024 | Sale | 647 | 420.39 | 271,992 | D |
14 Feb 2024 16:04 | VRTX | VERTEX PHARMACEUTICALS INC | LEIDEN JEFFREY M | Executive Chairman | 12 Feb 2024 | Sale | 2,009 | 419.22 | 842,213 | D |
13 Feb 2024 17:23 | VRTX | VERTEX PHARMACEUTICALS INC | TATSIS OURANIA | EVP, Chief Reg. & Quality Off. | 12 Feb 2024 | Sale | 314 | 420.24 | 131,955 | D |
13 Feb 2024 17:15 | VRTX | VERTEX PHARMACEUTICALS INC | SACHDEV AMIT | EVP Chief Patient & Ext Af Off | 12 Feb 2024 | Sale | 3,222 | 420.24 | 1,354,013 | D |
13 Feb 2024 16:56 | VRTX | VERTEX PHARMACEUTICALS INC | BILLER JONATHAN | EVP and Chief Legal Officer | 12 Feb 2024 | Sale | 1,738 | 418.77 | 727,822 | D |
13 Feb 2024 16:51 | VRTX | VERTEX PHARMACEUTICALS INC | ARBUCKLE STUART A | EVP, COO | 12 Feb 2024 | Sale | 4,295 | 420.24 | 1,804,931 | D |
13 Feb 2024 16:54 | VRTX | VERTEX PHARMACEUTICALS INC | ATKINSON EDWARD MORROW III | EVP, Chief Technical Ops. Off. | 12 Feb 2024 | Sale | 913 | 420.24 | 383,679 | D |
13 Feb 2024 16:46 | VRTX | VERTEX PHARMACEUTICALS INC | ALTSHULER DAVID | EVP, Global Research and CSO | 12 Feb 2024 | Sale | 3,145 | 420.24 | 1,321,655 | D |
13 Feb 2024 16:48 | VRTX | VERTEX PHARMACEUTICALS INC | AMBROSE KRISTEN | SVP & Chief Accounting Officer | 12 Feb 2024 | Sale | 1,374 | 420.24 | 577,410 | D |
10 Jan 2024 16:06 | VRTX | VERTEX PHARMACEUTICALS INC | LEIDEN JEFFREY M | Executive Chairman | 08 Jan 2024 | Sale | 6,648 | 419.07 | 2,785,977 | D |
04 Jan 2024 16:17 | VRTX | VERTEX PHARMACEUTICALS INC | WAGNER CHARLES F JR | EVP & Chief Financial Officer | 02 Jan 2024 | Sale | 3,000 | 405 | 1,215,000 | D |
19 Dec 2023 16:15 | VRTX | VERTEX PHARMACEUTICALS INC | KEWALRAMANI RESHMA | CEO & President | 15 Dec 2023 | Sale | 17,135 | 407 | 6,973,945 | D |
15 Dec 2023 16:33 | VRTX | VERTEX PHARMACEUTICALS INC | LEIDEN JEFFREY M | Executive Chairman | 13 Dec 2023 | Sale | 100 | 400.19 | 40,019 | D |
15 Dec 2023 16:33 | VRTX | VERTEX PHARMACEUTICALS INC | LEIDEN JEFFREY M | Executive Chairman | 13 Dec 2023 | Sale | 13,254 | 399.41 | 5,293,780 | D |
15 Dec 2023 16:20 | VRTX | VERTEX PHARMACEUTICALS INC | ARBUCKLE STUART A | EVP, COO | 13 Dec 2023 | Sale | 8,603 | 399 | 3,432,597 | D |
15 Dec 2023 16:23 | VRTX | VERTEX PHARMACEUTICALS INC | KEWALRAMANI RESHMA | CEO & President | 13 Dec 2023 | Sale | 5,098 | 397 | 2,023,906 | D |
21 Nov 2023 16:07 | VRTX | VERTEX PHARMACEUTICALS INC | WAGNER CHARLES F JR | EVP & Chief Financial Officer | 20 Nov 2023 | Sale | 3,000 | 349.88 | 1,049,640 | D |
17 Nov 2023 16:16 | VRTX | VERTEX PHARMACEUTICALS INC | SACHDEV AMIT | EVP Chief Patient & Ext Af Off | 15 Nov 2023 | Sale | 35 | 369.92 | 12,947 | D |
17 Nov 2023 16:11 | VRTX | VERTEX PHARMACEUTICALS INC | ALTSHULER DAVID | EVP, Global Research and CSO | 15 Nov 2023 | Sale | 19 | 369.92 | 7,028 | D |
16 Nov 2023 16:15 | VRTX | VERTEX PHARMACEUTICALS INC | BOZIC CARMEN | EVP and CMO | 14 Nov 2023 | Sale | 5,650 | 380.82 | 2,151,633 | D |
15 Nov 2023 16:16 | VRTX | VERTEX PHARMACEUTICALS INC | KEWALRAMANI RESHMA | CEO & President | 13 Nov 2023 | Sale | 5,097 | 377 | 1,921,569 | D |
08 Nov 2023 16:11 | VRTX | VERTEX PHARMACEUTICALS INC | SACHS BRUCE I | Director | 06 Nov 2023 | Sale | 11,250 | 385 | 4,331,250 | D |
02 Nov 2023 16:07 | VRTX | VERTEX PHARMACEUTICALS INC | BOZIC CARMEN | EVP and CMO | 31 Oct 2023 | Sale | 5,651 | 355.92 | 2,011,304 | D |
19 Oct 2023 16:18 | VRTX | VERTEX PHARMACEUTICALS INC | BOZIC CARMEN | EVP and CMO | 17 Oct 2023 | Sale | 5,651 | 373.25 | 2,109,236 | D |
19 Oct 2023 16:13 | VRTX | VERTEX PHARMACEUTICALS INC | BHATIA SANGEETA N. | Director | 17 Oct 2023 | Sale | 243 | 375 | 91,125 | D |
18 Oct 2023 16:17 | VRTX | VERTEX PHARMACEUTICALS INC | LEIDEN JEFFREY M | Executive Chairman | 16 Oct 2023 | Sale | 12,962 | 374 | 4,847,788 | D |
11 Oct 2023 16:14 | VRTX | VERTEX PHARMACEUTICALS INC | BHATIA SANGEETA N. | Director | 06 Oct 2023 | Sale | 242 | 360 | 87,120 | D |
05 Oct 2023 16:30 | VRTX | VERTEX PHARMACEUTICALS INC | BOZIC CARMEN | EVP and CMO | 03 Oct 2023 | Sale | 5,651 | 345.28 | 1,951,177 | D |
03 Oct 2023 16:07 | VRTX | VERTEX PHARMACEUTICALS INC | BILLER JONATHAN | EVP and Chief Legal Officer | 02 Oct 2023 | Sale | 610 | 346.76 | 211,524 | D |
21 Sep 2023 16:15 | VRTX | VERTEX PHARMACEUTICALS INC | BOZIC CARMEN | EVP and CMO | 19 Sep 2023 | Sale | 5,651 | 351 | 1,983,501 | D |
07 Sep 2023 16:29 | VRTX | VERTEX PHARMACEUTICALS INC | BOZIC CARMEN | EVP and CMO | 05 Sep 2023 | Sale | 5,651 | 352.66 | 1,992,882 | D |
03 May 2024 16:05 | VRTX | VERTEX PHARMACEUTICALS INC | BHATIA SANGEETA N. | Director | 02 May 2024 | Sale | 467 | 402.95 | 188,178 | D |
03 Apr 2024 16:02 | VRTX | VERTEX PHARMACEUTICALS INC | AMBROSE KRISTEN | SVP & Chief Accounting Officer | 02 Apr 2024 | Sale | 240 | 419 | 100,560 | D |
25 Aug 2023 16:14 | VRTX | VERTEX PHARMACEUTICALS INC | TATSIS OURANIA | EVP, Chief Reg. & Quality Off. | 23 Aug 2023 | Sale | 2,500 | 355 | 887,500 | D |
14 Aug 2023 16:09 | VRTX | VERTEX PHARMACEUTICALS INC | KEARNEY TERRENCE C | Director | 10 Aug 2023 | Sale | 10,000 | 350 | 3,500,000 | D |
14 Aug 2023 16:05 | VRTX | VERTEX PHARMACEUTICALS INC | SACHDEV AMIT | EVP, Chief Patient Officer | 10 Aug 2023 | Sale | 10,031 | 350 | 3,510,850 | D |
14 Aug 2023 16:08 | VRTX | VERTEX PHARMACEUTICALS INC | TATSIS OURANIA | EVP, Chief Reg. & Quality Off. | 10 Aug 2023 | Sale | 5,750 | 345.79 | 1,988,293 | D |
11 Aug 2023 16:05 | VRTX | VERTEX PHARMACEUTICALS INC | BHATIA SANGEETA N. | Director | 09 Aug 2023 | Sale | 242 | 345.51 | 83,613 | D |
11 Aug 2023 16:05 | VRTX | VERTEX PHARMACEUTICALS INC | ALTSHULER DAVID | EVP, Global Research and CSO | 09 Aug 2023 | Sale | 63 | 345.51 | 21,767 | D |
18 Jul 2023 16:17 | VRTX | VERTEX PHARMACEUTICALS INC | SACHS BRUCE I | Director | 17 Jul 2023 | Sale | 3,842 | 357.29 | 1,372,708 | D |
18 Jul 2023 16:17 | VRTX | VERTEX PHARMACEUTICALS INC | SACHS BRUCE I | Director | 17 Jul 2023 | Sale | 5,711 | 356.75 | 2,037,399 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)